Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

Killer immunoglobulin-like receptors (KIRs) are expressed on natural killer cells and some T-cell subsets and produce either activation or inhibitory signals upon binding with the appropriate human leucocyte antigen (HLA) ligand on target cells. Recent genetic association studies have implicated KIR...

Bibliografske podrobnosti
Main Authors:	Jones, D, Edgar, R, Ahmad, T, Cummings, JR, Jewell, D, Trowsdale, J, Young, N
Format:	Journal article
Jezik:	English
Izdano:	2006

Podobne knjige/članki

Genotypic diversity of the Killer Cell Immunoglobulin-like Receptors (KIR) and their HLA class I Ligands in a Saudi population
od: Suliman Y. Al Omar, et al.
Izdano: (2016-03-01)

Association of Killer Cell Immunoglobulin-like Receptor (KIR) Genes and their HLA Ligands with Susceptibility to Takayasu Arteritis in the Iranian Population
od: Fereshteh Beigmohammadi, et al.
Izdano: (2023-02-01)

Ulcerative colitis and HLA phenotype.
od: Cottone, M, et al.
Izdano: (1985)

Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
od: Gibson, P, et al.
Izdano: (1985)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
od: Daniela Maira Cardozo, et al.
Izdano: (2023-07-01)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
od: Antonino Tuttolomondo, et al.
Izdano: (2019-04-01)

The association of the killer cell immunoglobulin-like receptor (KIR) genotype distribution and HLA-C ligands in colorectal cancer in the eastern region of Saudi Arabia
od: Sarah Alqadheeb, et al.
Izdano: (2024-07-01)

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
od: Viktoria Varbanova, et al.
Izdano: (2019-11-01)

Relationship between KIR genotypes and HLA-ligands with SARS-CoV-2 infection in the Saudi population
od: Suliman Alomar, et al.
Izdano: (2023-01-01)

Natural Killer Cells and Cancer--Regulation by the Killer Cell Ig-like Receptors (KIR)
od: Amanda K. PURDY, et al.
Izdano: (2010-07-01)

Oral methotrexate in ulcerative colitis.
od: Cummings, JR, et al.
Izdano: (2005)

Ulcerative colitis and Crohn's disease--susceptibility genes and clinical patterns.
od: Jewell, D
Izdano: (1998)

KIR-HLA gene diversities and susceptibility to lung cancer
od: Marjan Hematian Larki, et al.
Izdano: (2022-10-01)

Ulcerative colitis.
od: Jewell, D
Izdano: (1975)

HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.
od: Aura Burian, et al.
Izdano: (2016-01-01)

Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis.
od: Barr, G, et al.
Izdano: (1987)

Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation
od: Davood Jafari, et al.
Izdano: (2017-06-01)

Killer Cell Ig-like Receptors (KIR)-Binding Assay for Tumor Cells
od: Loredana Cifaldi, et al.
Izdano: (2016-09-01)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
od: Jing-Jie Guo, et al.
Izdano: (2022-11-01)

Aetiopathogenesis of ulcerative colitis.
od: Jewell, D
Izdano: (1987)

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
od: Chrissy H Roberts, et al.
Izdano: (2014-03-01)

Association of genetic variants of KIR2DL4 and its ligand HLA-G gene with HCV susceptibility and chronicity
od: Ze-pei FENG, et al.
Izdano: (2023-03-01)

HLA TYPING OF ULCERATIVE COLITIS IN IRAN
od: Froutan, et al.
Izdano: (1996-06-01)

Azathioprine in ulcerative colitis.
od: Jewell, D, et al.
Izdano: (1972)

Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop
od: Misra, MK, et al.
Izdano: (2018)

Infliximab for ulcerative colitis.
od: Simmons, J, et al.
Izdano: (2002)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
od: Hatano, H, et al.
Izdano: (2013)

Proceedings: Etiology of ulcerative colitis.
od: Jewell, D
Izdano: (1973)

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.
od: Ying Qi, et al.
Izdano: (2006-08-01)

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
od: Rehan Mujeeb Faridi, et al.
Izdano: (2016-01-01)

Ulcerative colitis and sarcoidosis.
od: Barr, G, et al.
Izdano: (1986)

Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response
od: Vlad Andrei Cianga, et al.
Izdano: (2023-03-01)

Reaginic hypersensitivity in ulcerative colitis.
od: Jewell, D, et al.
Izdano: (1972)

Disodium azodisalicylate in ulcerative colitis.
od: Jewell, D, et al.
Izdano: (1981)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
od: Wong-Baeza, I, et al.
Izdano: (2011)

Genetics of ulcerative colitis.
od: Satsangi, J, et al.
Izdano: (1996)

Study on relationship between platelet transfusion efficacy and KIR-HLA receptor-ligand compatibility
od: Yu HAN, et al.
Izdano: (2023-07-01)

Linear IgA disease and ulcerative colitis.
od: Paige, D, et al.
Izdano: (1997)

Genome tuning through HLA and KIR gene clusters impact susceptibility to dengue
od: Neha Sharma, et al.
Izdano: (2023-09-01)

Benign intracranial hypertension and ulcerative colitis.
od: Jewell, D
Izdano: (1972)